Forebrain glucocorticoid receptors modulate anxiety-associated locomotor activation and adrenal responsiveness

被引:132
作者
Boyle, MP
Kolber, BJ
Vogt, SK
Wozniak, DF
Muglia, LJ
机构
[1] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA
关键词
glucocorticoid receptor; HPA axis; anxiety; knock-out mice; behavior; forebrain;
D O I
10.1523/JNEUROSCI.2173-05.2006
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Stress potently modulates anxiety- and depression-related behaviors. In response to stressors, the hypothalamic-pituitary-adrenal (HPA) axis is activated, resulting in the release of glucocorticoids from the adrenal cortex. These hormones act peripherally to restore homeostasis but also feed back to the CNS to control the intensity and duration of the stress response. Glucocorticoids act in limbic areas of the CNS to mediate the psychological and behavioral effects of stress. In this study, we investigate the effect of forebrain-specific disruption of the glucocorticoid receptor (GR) on stress- and anxiety-related behaviors. We demonstrate that mice with disruption of forebrain GR show alterations in stress- induced locomotor activation in a number of anxiety- related behavioral paradigms. These changes are associated with alterations in stress- induced HPA axis activation and, importantly, are not attenuated by chronic treatment with the tricyclic antidepressant imipramine. These data demonstrate the importance of forebrain GR in regulation of physiological and behavioral stress reactivity and suggest that distinct pathways regulate despair- and anxiety-related behaviors.
引用
收藏
页码:1971 / 1978
页数:8
相关论文
共 27 条
  • [11] Genetic disruption of mineralocorticoid receptor leads to impaired neurogenesis and granule cell degeneration in the hippocampus of adult mice
    Gass, P
    Kretz, O
    Wolfer, DP
    Berger, S
    Tronche, F
    Reichardt, HM
    Kellendonk, C
    Lipp, HP
    Schmid, W
    Schütz, G
    [J]. EMBO REPORTS, 2000, 1 (05) : 447 - 451
  • [12] Mice with targeted mutations of glucocorticoid and mineralocorticoid receptors: Models for depression and anxiety?
    Gass, P
    Reichardt, HM
    Strekalova, T
    Henn, F
    Tronche, F
    [J]. PHYSIOLOGY & BEHAVIOR, 2001, 73 (05) : 811 - 825
  • [13] Gorman J M, 1996, Depress Anxiety, V4, P160, DOI 10.1002/(SICI)1520-6394(1996)4:4<160::AID-DA2>3.0.CO
  • [14] 2-J
  • [15] Generalized anxiety disorder and major depressive disorder comorbidity: an example of genetic pleiotropy?
    Gorwood, P
    [J]. EUROPEAN PSYCHIATRY, 2004, 19 (01) : 27 - 33
  • [16] Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness
    Herman, JP
    Figueiredo, H
    Mueller, NK
    Ulrich-Lai, Y
    Ostrander, MM
    Choi, DC
    Cullinan, WE
    [J]. FRONTIERS IN NEUROENDOCRINOLOGY, 2003, 24 (03) : 151 - 180
  • [17] The corticosteroid receptor hypothesis of depression
    Holsboer, F
    [J]. NEUROPSYCHOPHARMACOLOGY, 2000, 23 (05) : 477 - 501
  • [18] The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
    Holsboer, F
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 1999, 33 (03) : 181 - 214
  • [19] Glucocorticoid receptors in anorexia nervosa and Cushing's disease
    Invitti, C
    Redaelli, G
    Baldi, G
    Cavagnini, F
    [J]. BIOLOGICAL PSYCHIATRY, 1999, 45 (11) : 1467 - 1471
  • [20] Corticosteroid receptors in the brain:: Gene targeting studies
    Kellendonk, C
    Gass, P
    Kretz, O
    Schütz, G
    Tronche, F
    [J]. BRAIN RESEARCH BULLETIN, 2002, 57 (01) : 73 - 83